Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
SillaJen, Inc.
Essen Biotech
University of Nebraska
Adela, Inc
Cancer Research UK
Case Comprehensive Cancer Center
Massive Bio, Inc.
Washington University School of Medicine
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Assistance Publique Hopitaux De Marseille
Stanford University
Taproot Health
Cancer Support Community, Research and Training Institute, Philadelphia
Hospital Universitario San Ignacio
Seoul National University Hospital
Shenzhen BinDeBio Ltd.
CureOne
Henry Ford Health System
National Institutes of Health Clinical Center (CC)
Butler Hospital
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center